Cabañog, Edna L.

HRN: 26-90-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
CEFTRIAXONE 1G (VIAL)
04/03/2025
04/09/2025
IV
2g
OD
Complicated UTI
Waiting Final Action 
04/04/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/04/2025
04/10/2025
IVTT
600mg
Q6
Lung Abscess
Waiting Final Action 
04/10/2025
CEFIXIME 200MG (CAP)
04/10/2025
04/16/2025
PO
200mg
BID
Complicated UTI
Waiting Final Action 
04/13/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/13/2025
04/19/2025
IV
4.5g
Q8h
T/c Sepsis, CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: